Pharmaceuticals, Inc. is a biopharmaceutical company developing products
for the eye care market. We are currently focused primarily on
commercializing prescription Avenova® for managing hygiene of the
eyelids and lashes in the United States.
Avenova is the only eye care
product formulated with a proprietary, stable and pure form of
hypochlorous acid called Neutrox®. By replicating the anti-microbial
chemicals used by white blood cells to fight infection, Neutrox has
proven in laboratory testing to have broad antimicrobial properties.
Avenova with Neutrox removes debris from the skin on eyelids and lashes
without burning or stinging.
We have developed additional commercial
products containing Neutrox, including our NeutroPhase® Skin and Wound
Cleanser for wound care and CelleRx® for the dermatology market. We have
partnerships for NeutroPhase in the U.S. as well as select overseas
markets, most notably China.
In addition to our Neutrox family of
products, we have also synthesized and developed a second category of
novel compounds aimed at harnessing the power of white blood cell
chemistry to address the global, topical anti-infective market. This
second product category includes auriclosene, our lead clinical-stage
Aganocide® compound, which is a patented, synthetic molecule with a
broad spectrum of activity against bacteria, viruses and fungi.